GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BenQ Medical Technology Corp (ROCO:4116) » Definitions » Beneish M-Score

BenQ Medical Technology (ROCO:4116) Beneish M-Score : -2.62 (As of Apr. 07, 2025)


View and export this data going back to 2002. Start your Free Trial

What is BenQ Medical Technology Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.62 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for BenQ Medical Technology's Beneish M-Score or its related term are showing as below:

ROCO:4116' s Beneish M-Score Range Over the Past 10 Years
Min: -2.72   Med: -2.56   Max: -1.42
Current: -2.62

During the past 13 years, the highest Beneish M-Score of BenQ Medical Technology was -1.42. The lowest was -2.72. And the median was -2.56.


BenQ Medical Technology Beneish M-Score Historical Data

The historical data trend for BenQ Medical Technology's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BenQ Medical Technology Beneish M-Score Chart

BenQ Medical Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.70 -2.51 -1.42 -2.16 -2.62

BenQ Medical Technology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.16 -2.26 -2.26 -2.58 -2.62

Competitive Comparison of BenQ Medical Technology's Beneish M-Score

For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BenQ Medical Technology's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where BenQ Medical Technology's Beneish M-Score falls into.


;
;

BenQ Medical Technology Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of BenQ Medical Technology for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9705+0.528 * 0.9737+0.404 * 0.981+0.892 * 1.0494+0.115 * 0.9898
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0852+4.679 * -0.022259-0.327 * 1.0494
=-2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was NT$917 Mil.
Revenue was 1319.046 + 1214.966 + 1176.191 + 1057.149 = NT$4,767 Mil.
Gross Profit was 406.677 + 370.701 + 358.535 + 312.451 = NT$1,448 Mil.
Total Current Assets was NT$3,098 Mil.
Total Assets was NT$5,274 Mil.
Property, Plant and Equipment(Net PPE) was NT$1,175 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$255 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,079 Mil.
Total Current Liabilities was NT$1,768 Mil.
Long-Term Debt & Capital Lease Obligation was NT$1,145 Mil.
Net Income was 26.288 + 26.639 + 29.206 + 22.698 = NT$105 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 86.799 + 82.804 + 23.473 + 29.145 = NT$222 Mil.
Total Receivables was NT$900 Mil.
Revenue was 1208.656 + 1154.785 + 1125.507 + 1054.053 = NT$4,543 Mil.
Gross Profit was 372.023 + 349.896 + 317.407 + 304.576 = NT$1,344 Mil.
Total Current Assets was NT$2,732 Mil.
Total Assets was NT$4,712 Mil.
Property, Plant and Equipment(Net PPE) was NT$1,068 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$229 Mil.
Selling, General, & Admin. Expense(SGA) was NT$947 Mil.
Total Current Liabilities was NT$1,376 Mil.
Long-Term Debt & Capital Lease Obligation was NT$1,104 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(916.928 / 4767.352) / (900.349 / 4543.001)
=0.192335 / 0.198184
=0.9705

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1343.902 / 4543.001) / (1448.364 / 4767.352)
=0.295818 / 0.303809
=0.9737

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3098.314 + 1174.776) / 5273.81) / (1 - (2732.343 + 1068.371) / 4712.161)
=0.189753 / 0.193424
=0.981

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4767.352 / 4543.001
=1.0494

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(229.222 / (229.222 + 1068.371)) / (255.214 / (255.214 + 1174.776))
=0.176652 / 0.178473
=0.9898

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1078.584 / 4767.352) / (947.168 / 4543.001)
=0.226244 / 0.208489
=1.0852

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1145.119 + 1768.178) / 5273.81) / ((1104.214 + 1376.217) / 4712.161)
=0.552408 / 0.526389
=1.0494

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(104.831 - 0 - 222.221) / 5273.81
=-0.022259

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

BenQ Medical Technology has a M-score of -2.62 suggests that the company is unlikely to be a manipulator.


BenQ Medical Technology Beneish M-Score Related Terms

Thank you for viewing the detailed overview of BenQ Medical Technology's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


BenQ Medical Technology Business Description

Traded in Other Exchanges
N/A
Address
7th Floor No.46, Zhou-Z Street, Neihu District, Taipei, TWN, 11493
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others.

BenQ Medical Technology Headlines

No Headlines